Dihydrotestosterone and Finasteride Effects on Alcohol Cue‐Elicited Brain Activity in Males With Heavy Episodic Drinking
Open Access
- 28 January 2026
- journal article
- research article
- Published by Wiley in Addiction Biology
- Vol. 31 (2) , e70123
Abstract
Preliminary animal and human studies have shown that blood dihydrotestosterone concentrations are increased in males with alcohol use disorder, and 5α‐reductase inhibitors, which decrease dihydrotestosterone concentrations, reduce alcohol consumption. To gain mechanistic insight, we studied the effects of reduced dihydrotestosterone concentrations following pharmacological 5α‐reductase inhibition on alcohol cue‐elicited brain activity and alcohol craving in males with problematic alcohol use. To this end, this randomized, placebo‐controlled, crossover challenge experiment investigated associations between dihydrotestosterone concentrations and brain functional magnetic resonance imaging (fMRI) activity during exposure to visual alcohol cues and alcohol craving following a single dose of 5 mg finasteride versus placebo in 50 males with heavy episodic drinking. We used finasteride because it specifically inhibits 5α‐reductase II activity, which is the main enzyme converting testosterone to dihydrotestosterone. Dihydrotestosterone concentrations were lower in the finasteride condition in comparison to the placebo condition, but not significantly associated with brain activation patterns or craving. In the exploratory analyses, we found higher brain activity during exposure to visual stimuli in the right and left caudate nuclei, the right superior frontal gyrus and the left insula in the finasteride condition versus the placebo condition. Moreover, finasteride versus placebo was associated with a higher wish to not drink alcohol. The results of this experimental study do not support the à priori hypothesis that dihydrotestosterone concentrations play a role in brain activation during exposure to visual alcohol cues, but indicate that finasteride effects may be mediated by other pathways. Future studies are requested to investigate the effects of reduced dihydrotestosterone concentrations over a longer time and to shed light on the molecular mechanisms underlying the here observed effects of finasteride. Trial Registration: DRKS00020569Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (402170461 – TRR265)
This publication has 32 references indexed in Scilit:
- Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatumAddiction, 2010
- Inhibition of 5α‐Reduced Steroid Biosynthesis Impedes Acquisition of Ethanol Drinking in Male C57BL/6J MiceAlcohol, Clinical and Experimental Research, 2008
- Studies on Neurosteroids XXV. Influence of a 5.ALPHA.-Reductase Inhibitor, Finasteride, on Rat Brain Neurosteroid Levels and MetabolismBiological and Pharmaceutical Bulletin, 2008
- The Reliability and Validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German General Practice Population SampleJournal of Studies on Alcohol, 2006
- Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: Potential role of endogenous neurosteroids?Alcohol, 2005
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by FinasterideNeuropsychopharmacology, 2005
- Stereotaxic Display of Brain LesionsBehavioural Neurology, 2000
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasterideClinical Pharmacology & Therapeutics, 1998
- Development and Initial Validation of a Measure of Drinking Urges in Abstinent AlcoholicsAlcohol, Clinical and Experimental Research, 1995
- Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.The Journal of Clinical Endocrinology & Metabolism, 1992